Zevra Therapeutics, Inc. (ZVRA)
12.06
+0.32
(+2.73%)
USD |
NASDAQ |
Sep 01, 16:00
12.06
0.00 (0.00%)
After-Hours: 20:00
Zevra Therapeutics Cash from Operations (Annual) : -1.598M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -1.598M |
| December 31, 2024 | -69.66M |
| December 31, 2023 | -33.54M |
| December 31, 2022 | -18.72M |
| December 31, 2021 | 7.558M |
| December 31, 2020 | -1.939M |
| December 31, 2019 | -23.74M |
| Date | Value |
|---|---|
| December 31, 2018 | -54.39M |
| December 31, 2017 | -33.10M |
| December 31, 2016 | -29.77M |
| December 31, 2015 | -20.27M |
| December 31, 2014 | -14.67M |
| December 31, 2013 | -4.316M |
| December 31, 2012 | -4.434M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Innoviva, Inc. | 196.93M |
| Collegium Pharmaceutical, Inc. | 329.32M |
| Johnson & Johnson | 24.53B |
| Ligand Pharmaceuticals, Inc. | 49.36M |
| Harrow, Inc. | 43.86M |